Confirmed Nipah virus (NiV) infection is a severe viral illness with very limited established treatment options. Prompt, structured management is essential once laboratory confirmation is obtained.
On confirmation of NiV infection, management centres on intensive supportive care alongside antiviral drug treatment. Available antiviral options include an oral antiviral agent and, under specific circumstances, a monoclonal antibody that is administered only on compassionate grounds — after discussion with the patient or their legal authorised representative.